Menu

Spotlight pitch finalist (Basel Switzerland 20-22nd March, 2023)

Inhibitec is selected as finalist in the BIO-Europe Spring Startup Spotlight competition. This exciting competition offers entrepreneurs an affordable opportunity to engage with top-tier investors and other important players in the biotech industry to take their business to the next level.

Link to the article

Share the Post:

Related Posts

New Publication in the Journal of Translational Medicine

We are thrilled to announce the publication of our study, “Humanized anti-BAMBI monoclonal antibody as a novel therapeutic strategy for psoriatic arthritis”, in Journal of...

Great news to start 2026!

Inhibitec has received funding ((€3,533.45) through the Planes de Promoción Comercial program (NM25-PC-109), supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN). This grant...

We are pleased to welcome our new colleague Diego Romero to the team!

Inhibitec Antibodies has been selected for the ‘Programa Personal Técnico I+D’, supported by Sociedad para el Desarrollo Regional de Cantabria (SODERCAN), enabling us to expand...

Scroll to Top